Evidence-Based Medicine Guidelines
Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long-acting Beta2-agonist in Addition to Tiotropium Versus Either Agent Alone for Chronic Obstructive Pulmonary Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305017/all/_________Long_acting_beta2_agonist_in_addition_to_tiotropium_versus_either_agent_alone_for_chronic_obstructive_pulmonary_disease______.
Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305017/all/_________Long_acting_beta2_agonist_in_addition_to_tiotropium_versus_either_agent_alone_for_chronic_obstructive_pulmonary_disease______. Accessed April 18, 2025.
Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305017/all/_________Long_acting_beta2_agonist_in_addition_to_tiotropium_versus_either_agent_alone_for_chronic_obstructive_pulmonary_disease______
Long-acting Beta2-agonist in Addition to Tiotropium Versus Either Agent Alone for Chronic Obstructive Pulmonary Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305017/all/_________Long_acting_beta2_agonist_in_addition_to_tiotropium_versus_either_agent_alone_for_chronic_obstructive_pulmonary_disease______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long-acting beta2-agonist in addition to tiotropium versus either agent alone for chronic obstructive pulmonary disease
ID - 1305017
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305017/all/_________Long_acting_beta2_agonist_in_addition_to_tiotropium_versus_either_agent_alone_for_chronic_obstructive_pulmonary_disease______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
